Výsledky vyhledávání - "P. B. Fourie"

The impact of implementing a Xpert MTB/RIF algorithm on drug-sensitive pulmonary tuberculosis: a retrospective analysis

Autor: N. Muditambi, James McIntyre, Remco P. H. Peters, M. Maswanganyi, Helen Struthers, Kate Rees, P. B. Fourie, Jean Railton

Publikováno v: Epidemiology and Infection, 146(2), 246-255. Cambridge University Press
Epidemiol Infect

SUMMARYXpert MTB/RIF (Xpert) is the preferred first-line test for all persons with tuberculosis (TB) symptoms in South Africa in line with a diagnostic algorithm. This study evaluates pre- and post-implementation trends in diagnostic practices for dr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c1133b1bad45fc1b800a6d465fad683
https://doi.org/10.1017/s0950268817002746

Zobrazit plný text záznamu

Xpert(®) MTB/RIF detection of Mycobacterium tuberculosis from sputum collected in molecular transport medium

Autor: L T, Daum, P B, Fourie, R P H, Peters, J D, Rodriguez, S A, Worthy, M, Khubbar, S, Bhattacharyya, M S, Gradus, T, Mboneni, E E, Marubini, C, Helm, J P, Chambers, G W, Fischer

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 20(8)

The Xpert(®) MTB/RIF assay is widely used for Mycobacterium tuberculosis detection. However, specimen transport remains a challenge. PrimeStore Molecular Transport Medium(®) (PS-MTM) inactivates specimens and stabilizes DNA/RNA at ambient temperatu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1e8137a501c1587c78b4d2a437db063a
https://pubmed.ncbi.nlm.nih.gov/27393549

Zobrazit plný text záznamu

Spray Dried Aerosol Particles of Pyrazinoic Acid Salts for Tuberculosis Therapy. [Corrected]

Autor: P G, Durham, Y, Zhang, N, German, N, Mortensen, J, Dhillon, D A, Mitchison, P B, Fourie, A J, Hickey

Publikováno v: Molecular pharmaceutics. 12(8)

Tuberculosis is the most serious infectious disease caused by a single organism, Mycobacterium tuberculosis (Mtb). The standard of care is a protracted and complex drug treatment regimen made more complicated and of longer duration by the incidence o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::67203cbce91451794ef893dc17c58f2f
https://pubmed.ncbi.nlm.nih.gov/26394135

Zobrazit plný text záznamu

Molecular detection of Mycobacterium tuberculosis from sputum transported in PrimeStore(®) from rural settings

Autor: L T, Daum, R P H, Peters, P B, Fourie, K, Jonkman, S A, Worthy, J D, Rodriguez, N A, Ismail, S V, Omar, G W, Fischer

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 19(5)

Mopani District, South Africa.To explore remote, molecular detection of Mycobacterium tuberculosis from sputum transported using PrimeStore(®) Molecular Transport Medium (PS-MTM) compared to settings where microscopy or Xpert(®) MTB/RIF is used as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::392a28f9aacc054e50cceb8f7b0af7f8
https://pubmed.ncbi.nlm.nih.gov/25868023

Zobrazit plný text záznamu

A review of the determination of the early bactericidal activity of various antituberculosis agents

Autor: H. I. Seifart, B. W. Van de Wal, P. B. Fourie, F. A. Sirgel, D. P. Parkin Parkin, Amour Venter, J. S. Maritz, Peter R. Donald

Publikováno v: Suid-Afrikaanse Tydskrif vir Natuurwetenskap en Tegnologie. 22:79-88

Die vroee bakterisidiese aktiwiteit (VBA) van ’n antituberkulosemiddel is die daaglikse afname van M tuberculosis in log10 kolonievormende eenhede per ml sputum, tydens die eerste twee dae van behandeling met die middel. Dit weerspieel die vermoe v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f887234dd83c0a7fe569719f75569e45
https://doi.org/10.4102/satnt.v22i2/3.215

Zobrazit plný text záznamu

’n Oorsig van die bepaling van die vroeë bakterisidiese aktiwiteit van verskeie antituberkulosemiddels

Autor: P. R. Donald, F. A. Sirgel, A. Venter, P. B. Fourie, D. P. Parkin Parkin, H. I. Seifart, B. W. van de Wal, J. S. Maritz

Publikováno v: South African Journal of Science and Technology, Vol 22, Iss 2&3, Pp 79-88 (2003)
South African Journal of Science and Technology, Vol 22, Iss 2/3, Pp 79-88 (2003)

Die vroeë bakterisidiese aktiwiteit (VBA) van ’n antituberkulosemiddel is die daaglikse afname van M tuberculosis in log10 kolonievormende eenhede per ml sputum, tydens die eerste twee dae van behandeling met die middel. Dit weerspieël die vermo�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0278d09e7266c4fb99772c5bb35943fa
http://www.satnt.ac.za/index.php/satnt/article/view/215

Zobrazit plný text záznamu

Modification to improve efficiency of sampling schedules for BA/BE testing of FDC anti-tuberculosis drugs

Autor: G A, Gabriels, H, McIlleron, P J, Smith, P I, Folb, P B, Fourie

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 11(2)

The assessment of rifampicin (RMP) containing fixed-dose combination (FDC) formulations using in vivo bioequivalence testing is widely accepted. It would be advantageous for both the drug regulatory authorities and drug manufacturers, for optimum min

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::304a096821884d0ba5726515596c5f12
https://pubmed.ncbi.nlm.nih.gov/17263289

Zobrazit plný text záznamu

Early bactericidal activity of antituberculosis agents

Autor: B. W. Van de Wal, P. B. Fourie, D. P. Parkin, H. I. Seifart, Amour Venter, J.S. Maritz, F. A. Sirgel, Peter R. Donald

Publikováno v: Expert review of anti-infective therapy. 1(1)

The early bactericidal activity (EBA) of an antituberculosis agent is arbitrarily defined as the fall in log(10) colony forming units (cfu) of Mycobacterium tuberculosis per ml sputum per day during the first 2 days of treatment. Determining the EBA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09ff7ab0e3a98e3d1928431ee8d6deb7
https://pubmed.ncbi.nlm.nih.gov/15482107

Zobrazit plný text záznamu

The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations

Autor: G, Pillai, G A, Ellard, P J, Smith, P B, Fourie

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 5(8)

The perceived need for simple, non-invasive methods of assessing the relative bioavailability of rifampicin in fixed-dose combination (FDC) anti-tuberculosis formulations.To compare the performance of methods based on urinary excretion data with thos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bea7a1a97f5abe13a075560d1a4e3c8b
https://pubmed.ncbi.nlm.nih.gov/11495257

Zobrazit plný text záznamu

Evaluation of a rapid test for HIV antibodies in saliva and blood

Autor: L M, Webber, C, Swanevelder, W O, Grabow, P B, Fourie

Publikováno v: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 90(10)

To test whole blood and saliva for HIV antibodies (anti-HIV) using a rapid test strip capillary flow immunoassay, and to correlate the test strip results with blood specimen results obtained from routine diagnostic anti-HIV assays.A prospective pilot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9e19455ccca859b68cdbf5de8793c999
https://pubmed.ncbi.nlm.nih.gov/11081107

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání